首页> 外国专利> METHOD FOR PREDICTING THE CLINICAL EFFECT AFTER A KIDNEY REVASCULARIZATION SURGERY IN PATIENTS WITH ISCHEMIC NEPHROPATHY

METHOD FOR PREDICTING THE CLINICAL EFFECT AFTER A KIDNEY REVASCULARIZATION SURGERY IN PATIENTS WITH ISCHEMIC NEPHROPATHY

机译:肾缺血性肾病患者肾脏复律手术后的临床疗效预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to cardiovascular surgery, and can be used when predicting the clinical effect of kidney revascularization in patients with renal artery stenosis and ischemic nephropathy. To do this, the urine is tested for microalbuminuria. Daily urine is collected from patient, volume is measured to accuracy of 5 ml, 50 ml of spontaneous urine are taken in a separate container. Then, urine is tested for microalbuminuria by immunoturbidimetry. At microalbuminuria level less than 30 mg/day or less than 20 mg/l of a spontaneous urine sample, operative treatment in the volume of angioplasty and stenting of renal arteries is justified with a high probability of recovery of renal function after surgery. At microalbuminuria level of more than 30 mg/day or more than 20 mg/l of a spontaneous urine sample, the probability of restoration of renal function is low and surgical treatment is ineffective.;EFFECT: method provides the most accurate prediction of the clinical effect of kidney revascularization in this category of patients due to the specificity of the method allowing to assess the degree of damage to the glomerular apparatus of the kidneys.;1 cl, 2 ex
机译:发明领域本发明涉及医学,即心血管外科,可用于预测肾动脉狭窄和缺血性肾病患者的肾脏血运重建的临床效果。为此,对尿液进行微量白蛋白尿测试。每天从患者那里收集尿液,量取至5 ml的准确度,将50 ml的自发尿液放入另一个容器中。然后,通过免疫比浊法检测尿液中的微量白蛋白尿。如果微量白蛋白尿的水平低于自发尿液样本的30毫克/天或低于20毫克/升,那么在血管成形术和肾动脉支架置入术中进行手术治疗是合理的,手术后肾功能恢复的可能性很高。自发尿液样本中微量白蛋白尿超过30 mg / day或超过20 mg / l时,肾功能恢复的可能性低且手术治疗无效。;效果:该方法可为临床提供最准确的预测由于该方法的特异性可以评估肾脏对肾小球装置的损害程度,因此在该类患者中肾血运重建的效果。[1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号